24 years of historical data (2002–2025) · Healthcare · Medical - Healthcare Plans
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Molina Healthcare, Inc. trades at 17.3x earnings, 18% below its 5-year average of 21.1x, sitting at the 27th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.7x, the stock trades at a discount of 27%.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.9B | $9.2B | $16.8B | $21.0B | $19.3B | $18.6B | $12.7B | $8.7B | $7.8B | $4.3B | $3.0B |
| Enterprise Value | $7.6B | $8.9B | $15.2B | $18.5B | $17.7B | $16.6B | $10.9B | $7.7B | $6.4B | $3.3B | $1.9B |
| P/E Ratio → | 17.27 | 19.46 | 14.25 | 19.24 | 24.39 | 28.27 | 18.92 | 11.82 | 11.02 | — | 58.98 |
| P/S Ratio | 0.17 | 0.20 | 0.41 | 0.62 | 0.60 | 0.67 | 0.66 | 0.52 | 0.41 | 0.22 | 0.17 |
| P/B Ratio | 2.00 | 2.26 | 3.74 | 4.98 | 6.52 | 7.09 | 6.08 | 4.44 | 4.73 | 3.21 | 1.84 |
| P/FCF | — | — | 30.87 | 13.30 | 28.33 | 9.13 | 7.02 | 23.54 | — | 5.98 | 6.11 |
| P/OCF | — | — | 26.08 | 12.63 | 24.99 | 8.80 | 6.74 | 20.40 | — | 5.34 | 4.51 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Molina Healthcare, Inc.'s enterprise value stands at 7.8x EBITDA, 29% below its 5-year average of 11.1x. The Healthcare sector median is 13.8x, placing the stock at a 43% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.20 | 0.38 | 0.54 | 0.55 | 0.60 | 0.56 | 0.46 | 0.34 | 0.16 | 0.11 |
| EV / EBITDA | 7.82 | 9.10 | 8.06 | 10.62 | 13.12 | 14.42 | 9.38 | 6.84 | 5.10 | — | 3.82 |
| EV / EBIT | 9.78 | 11.37 | 8.93 | 11.78 | 15.09 | 16.68 | 10.29 | 7.31 | 5.76 | — | 6.09 |
| EV / FCF | — | — | 28.03 | 11.74 | 25.96 | 8.13 | 6.02 | 20.93 | — | 4.56 | 3.75 |
Margins and return-on-capital ratios measuring operating efficiency
Molina Healthcare, Inc. earns an operating margin of 1.7%. Operating margins have compressed from 4.6% to 1.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 11.0% is modest. ROIC of 17.4% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 11.7% | 12.7% | 12.3% | 11.8% | 13.8% | 14.5% | 13.9% | 9.5% | 10.0% |
| Operating Margin | 1.7% | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.6% | 6.2% | 6.0% | -2.8% | 1.7% |
| Net Profit Margin | 1.0% | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.0% | 11.0% | 27.1% | 30.4% | 28.3% | 27.9% | 33.2% | 40.9% | 47.4% | -34.3% | 0.5% |
| ROA | 3.0% | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.1% |
| ROIC | 17.4% | 17.4% | 54.4% | 76.1% | 91.0% | 174.3% | 125.5% | 123.0% | 283.2% | -104.7% | 35.0% |
| ROCE | 9.8% | 9.8% | 23.6% | 25.8% | 22.1% | 21.0% | 26.7% | 32.5% | 38.9% | -19.2% | 10.9% |
Solvency and debt-coverage ratios — lower is generally safer
Molina Healthcare, Inc. carries a Debt/EBITDA ratio of 4.0x, which is highly leveraged (30% above the sector average of 3.1x). The company holds a net cash position — cash of $4.2B exceeds total debt of $4.0B, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 4.1x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.97 | 0.97 | 0.69 | 0.57 | 0.81 | 0.91 | 1.12 | 0.76 | 0.89 | 1.62 | 1.00 |
| Debt / EBITDA | 4.05 | 4.05 | 1.65 | 1.37 | 1.77 | 2.08 | 2.02 | 1.31 | 1.16 | — | 3.37 |
| Net Debt / Equity | — | -0.07 | -0.34 | -0.58 | -0.54 | -0.78 | -0.86 | -0.49 | -0.83 | -0.76 | -0.71 |
| Net Debt / EBITDA | -0.31 | -0.31 | -0.82 | -1.41 | -1.20 | -1.78 | -1.55 | -0.85 | -1.09 | — | -2.41 |
| Debt / FCF | — | — | -2.84 | -1.56 | -2.37 | -1.00 | -0.99 | -2.61 | — | -1.42 | -2.36 |
| Interest Coverage | 4.07 | 4.07 | 14.47 | 14.43 | 10.66 | 8.50 | 10.57 | 12.00 | 9.83 | -4.70 | 3.03 |
Net cash position: cash ($4.2B) exceeds total debt ($4.0B)
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.69x means Molina Healthcare, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.54x to 1.69x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | 1.69 | 1.62 | 1.54 | 1.47 | 1.43 | 1.59 | 1.83 | 1.52 | 1.35 | 1.31 |
| Quick Ratio | 1.69 | 1.69 | 1.62 | 1.54 | 1.47 | 1.43 | 1.59 | 1.83 | 1.52 | 1.35 | 1.31 |
| Cash Ratio | 0.58 | 0.58 | 1.14 | 1.11 | 1.09 | 1.08 | 1.21 | 1.35 | 1.06 | 1.03 | 1.00 |
| Asset Turnover | — | 2.92 | 2.60 | 2.29 | 2.60 | 2.27 | 2.04 | 2.48 | 2.64 | 2.35 | 2.38 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Molina Healthcare, Inc. returns 12.6% to shareholders annually primarily through share buybacks. The earnings yield of 5.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.8% | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | — | 1.7% |
| FCF Yield | — | — | 3.2% | 7.5% | 3.5% | 11.0% | 14.3% | 4.2% | — | 16.7% | 16.4% |
| Buyback Yield | 12.6% | 10.9% | 6.0% | 0.3% | 2.1% | 0.7% | 4.8% | 0.5% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 12.6% | 10.9% | 6.0% | 0.3% | 2.1% | 0.7% | 4.8% | 0.5% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $53M | $58M | $58M | $59M | $59M | $60M | $64M | $67M | $56M | $56M |
Compare MOH with 1 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| MOHYou | $8B | 17.3 | 7.8 | — | — | 1.7% | 11.0% | 17.4% | 4.0 |
| CNC | $22B | -3.3 | — | 5.1 | 12.2% | -3.9% | -28.7% | -22.2% | — |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 24 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how MOH stacks up against sector leader Centene Corporation.
Start ComparisonMolina Healthcare, Inc.'s current P/E ratio is 17.3x. The historical average is 28.4x. This places it at the 27th percentile of its historical range.
Molina Healthcare, Inc.'s current EV/EBITDA is 7.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.0x.
Molina Healthcare, Inc.'s return on equity (ROE) is 11.0%. The historical average is 15.8%.
Based on historical data, Molina Healthcare, Inc. is trading at a P/E of 17.3x. This is at the 27th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Molina Healthcare, Inc. has 1.7% operating margin.
Molina Healthcare, Inc.'s Debt/EBITDA ratio is 4.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.